Tenecteplase no longer 'off label' for acute ischemic stroke
UC expert featured in MedCentral article
The University of Cincinnati's Yasmin Aziz was featured in a MedCentral article discussing the recent FDA approval of the drug tenecteplase (TNK) for treatment of acute ischemic stroke.
Trials of alteplase, also called tPA, were pioneered at the University of Cincinnati in the late 1980s, representing the first proven treatment for ischemic stroke. TNK is a more recently developed clot-busting drug that can be administered in a single IV injection within seconds.
Aziz said many academic health centers and private institutions have been using TNK off label since data from the 2022 ACT trial was published.
While there are new dosing instructions associated with the FDA approval, Aziz said the speed of delivering TNK makes it appealing. Administering tPA requires a 1-minute infusion followed by a 60-minute infusion of the rest of the dosage, while TNK requires a 5-second infusion.
“I will tell you, the ease of use is really what’s going to get people to change," said Aziz, MD, director, Acute Stroke Trials; associate director, Vascular Neurology Fellowship; and assistant professor in the Department of Neurology and Rehabilitation Medicine in UC's College of Medicine; UC Health neurologist; director, NIH StrokeNet Digital Media; and co-investigator, NIH StrokeNet Ohio Valley Regional Coordinating Center.
“I think this will hopefully allow us to treat more patients faster with less chance of error,” she continued. “It’s much easier to give a drug like tenecteplase in a moving ambulance."
Featured photo at top of illustration of brain with stroke symptoms. Photo/PeterSchreiber.media/iStock.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Position-specific helmets may not improve protection
March 16, 2026
Local 12 highlighted a new study by biomedical engineering researchers that looked at how well new football helmets protected players from impacts that can cause concussions.
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.